期刊文献+

复方五指柑胶囊治疗急性胃肠炎的多中心临床研究 被引量:2

Multi-center clinical study of Compound Wuzhigan Capsule in treatment of acute gastroenteritis
原文传递
导出
摘要 目的观察复方五指柑胶囊治疗急性胃肠炎的疗效及安全性。方法采用多中心、随机、双盲、阳性平行对照试验方法,治疗组120例口服复方五指柑胶囊,2粒/次,3次/d。对照组120例口服复方五指柑片,4片/次,3次/d。两组患者均治疗3 d。观察两组的临床综合疗效、中医证候疗效、单个中医证候疗效。结果治疗后,治疗组和对照组临床综合疗效总有效率分别为98.32%、98.31%,两组比较差异无统计学意义。治疗组和对照组中医证候疗效总有效率分别为98.32%、98.31%,两组比较差异无统计学意义。两组均可显著改善便次改变、便质改变、排便异常、脘腹胀痛、恶心呕吐等主症,两组的主症疗效差异均无统计学意义。结论复方五指柑胶囊治疗急性胃肠炎疗效确切,安全性良好。 Objective To observe the curative effect and safety of Compound Wuzhigan Capsule in treatment of acute gastroenteritis. Methods A multi-center randomized double-blind positive parallel controlled trial method was adopted. The patients(120 cases) in the treatment group were po administered with Compound Wuzhigan Capsule, 2 grains/time, three times daily. The patients(120 cases) in the control group were po administered with Compound Wuzhigan Tablet, 4 tablets/time, three times daily. The clinical comprehensive efficacy, efficacy of TCM syndrome, and efficacy of single syndromes in two groups were observed. Results After treatment, the clinical comprehensive efficacies in the treatment and control groups were 98.32% and 98.31%, respectively, with no difference between the two groups. The efficacies of TCM syndrome in two groups were 98.32% and 98.31%, respectively, with no difference between the two groups. Two groups could significantly improve the change of defecate frequency and nature, abnormal defecate, abdominal distension painful, nausea, and vomiting, with no difference between the two groups. Conclusion Compound Wuzhigan Capsule has good clinical effect in treatment of acute gastroenteritis with good security.
出处 《现代药物与临床》 CAS 2014年第11期1257-1261,共5页 Drugs & Clinic
基金 广东省经贸委省级挖潜改造资金重点产业技术创新项目(2006855007)
关键词 复方五指柑胶囊 复方五指柑片 急性胃肠炎 综合疗效 Compound Wuzhigan Capsule Compound Wuzhigan Tablet acute gastroenteritis comprehensive efficacy
  • 相关文献

参考文献6

  • 1孙虹,胡淑毅,张剑波.复方五指柑胶囊药效学研究[J].时珍国医国药,2009,20(4):976-978. 被引量:8
  • 2孙虹,沈琳,胡雅静,胡淑毅,许睿,方永奇,李翎.复方五指柑胶囊毒理学研究[J].中国医药导报,2011,8(1):50-52. 被引量:3
  • 3王承党, 莫剑忠.江绍基胃肠病学[M].上海: 上海科学技术出版社, 2001: 381-383.
  • 4邵明立.《药品注册管理办法》附件1: 天然药物注册分类及申报资料要求 [S].2007.
  • 5国家食品药品监督管理局药品审评中心.中药新药治疗急性胃炎的临床研究指导原则 [S].1995.
  • 6国家食品药品监督管理局药品审评中心.中药新药治疗泄泻的临床研究指导原则 [S].2002.

二级参考文献6

  • 1李仪奎.中药药理实验方法学[M].上海:上海科技出版社,1989.36.
  • 2中华人民共和国卫生部药政管理局.中药新药研究指南(药学、药理学、毒理学)[S].北京:中国医药科技出版社,2005:203-205,194-198,205.
  • 3郑虎占.中药现代研究与应用[M].北京:学苑出版社,1998.1484-2373.
  • 4江苏新医学院.中药大辞典[M].上海:上海科技出版社,1986.739.
  • 5肖培根.新编中药志[M].北京:化学工业出版社,2002.201.
  • 6国家中医药管理局《中华本草》编委会.中华本草[M].上海:上海科技出版社,1996.911—911.

共引文献8

同被引文献34

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部